Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase.
about
Transformation and scattering activities of the receptor tyrosine kinase RON/Stk in rodent fibroblasts and lack of regulation by the jaagsiekte sheep retrovirus receptor, Hyal2Crystal Structure of the Sema-PSI Extracellular Domain of Human RON Receptor Tyrosine KinaseThe soluble sema domain of the RON receptor inhibits macrophage-stimulating protein-induced receptor activationThe RON receptor tyrosine kinase in pancreatic cancer pathogenesis and its potential implications for future targeted therapiesRon receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell linesAn unusual function of RON receptor tyrosine kinase as a transcriptional regulator in cooperation with EGFR in human cancer cells.Hyaluronan and layilin mediate loss of airway epithelial barrier function induced by cigarette smoke by decreasing E-cadherin.Isolation of Fully Human Antagonistic RON Antibodies Showing Efficient Block of Downstream Signaling and Cell Migration.Human RON receptor tyrosine kinase induces complete epithelial-to-mesenchymal transition but causes cellular senescence.Intron retention in the alternatively spliced region of RON results from weak 3' splice site recognition.Variant RONΔ160 of the RON receptor tyrosine kinase promotes the growth and invasion in vitro and in vivo in gastric cancer cell lines.The monoclonal antibody Zt/f2 targeting RON receptor tyrosine kinase as potential therapeutics against tumor growth-mediated by colon cancer cells.RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humansOncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers.Recepteur d'Origine nantais (RON) tyrosine kinase splicing variants lacking exons 18 and 19 occur ubiquitously in lung cancerOncogenic transformation by the jaagsiekte sheep retrovirus envelope protein.A distinct molecular profile associated with mucinous epithelial ovarian cancer.The RON receptor tyrosine kinase is a potential therapeutic target in Burkitt lymphoma.Significance of the entire C-terminus in biological activities mediated by the RON receptor tyrosine kinase and its oncogenic variant RON160The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells.Prognostic significance of MST1R dysregulation in renal cell tumorsRON kinase isoforms demonstrate variable cell motility in normal cells.Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasionPhase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors.Expression of the receptor tyrosine kinase recepteur d'origine nantais and its association with tumor progression in hypopharyngeal cancer.RON is associated with tumor progression via the inhibition of apoptosis and cell cycle arrest in human gastric cancer.Knockdown of RON inhibits AP-1 activity and induces apoptosis and cell cycle arrest through the modulation of Akt/FoxO signaling in human colorectal cancer cells.Mechanisms of RON-mediated epithelial-mesenchymal transition in MDCK cells through the MAPK pathway.Targeting acute hypoxic cancer cells by doxorubicin-immunoliposomes directed by monoclonal antibodies specific to RON receptor tyrosine kinase.Altered exon usage in the juxtamembrane domain of mouse and human RON regulates receptor activity and signaling specificity.Integrin alpha6beta4-erbB2 complex inhibits haptotaxis by up-regulating E-cadherin cell-cell junctions in keratinocytes.A missing link between RON expression and oncological outcomes in resected left-sided pancreatic cancer.The Ron receptor tyrosine kinase is not required for adenoma formation in Apc(Min/+) miceGeldanamycins trigger a novel Ron degradative pathway, hampering oncogenic signaling.Mechanisms of cytoplasmic {beta}-catenin accumulation and its involvement in tumorigenic activities mediated by oncogenic splicing variant of the receptor originated from Nantes tyrosine kinase.Inhibitors of HGFA, Matriptase, and Hepsin Serine Proteases: A Nonkinase Strategy to Block Cell Signaling in Cancer.Receptor tyrosine kinases MET and RON as prognostic factors in diffuse large B-cell lymphoma patients receiving R-CHOP.Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities.Expression of Hepatocyte Growth Factor-Like Protein in Human Wound Tissue and Its Biological Functionality in Human Keratinocytes.
P2860
Q24798381-C68D84CA-29E7-4B0C-AC1F-6F6C829EEB39Q27671005-F14A2292-5E10-49F1-A3C7-AF6EC56867CDQ28181737-32B2419B-F609-4C59-B00E-E56FE4E6EB80Q33563635-6A728507-B77D-45A4-95F0-8793CD797E4CQ34041328-5BE9F2B7-8C9D-416A-9E0F-D65F69F67A41Q34042332-B9E53396-64D1-4B1E-A457-B69842E972B3Q34304839-C1396385-5EE4-4407-9539-B5B9AE5145B1Q34518350-5E404201-CC29-4FE0-A369-27A61D56DC6FQ34976789-7B504465-6B5A-490E-BE4E-202A496D60CDQ35025393-F3E6C5B3-C209-4F66-8347-2D2A100F53A9Q35079037-414F68D7-A251-4AF6-BDB0-88918D87D607Q35124768-14EFE623-FDE9-4B13-8B13-6F8C024D42D1Q35146597-2833BE30-F14F-4807-86D4-8CCF49FE49EEQ35758261-62822FDC-4ACA-43B8-897A-D9AF3B04FF51Q36488410-E2B7D037-9A1E-4B5A-841F-59F5461947FAQ36492850-80DD29FB-297F-4820-BA77-2EDAD02C0FFBQ36565761-954981EC-A19B-41DE-B0BF-5827110011E7Q36614490-871C44C8-604E-4975-A5F1-1F9AB754641DQ36887780-1B098962-B594-4454-9652-DF90771AAD33Q36975164-CCF9E880-CACE-4667-A205-92B797F746DBQ37066428-69C6C9DA-E8B5-4D2E-B6F9-98845E26B87EQ37215552-F185D228-FFE9-483E-BE5A-88D12734FB62Q37253779-25D43AA8-1B54-4149-8445-715B817BC7A0Q37340100-44AEACC3-C72E-43E4-90BE-CE9D6017349AQ38978586-8A20FEA7-92A2-40A6-9F6B-601BAC5366AAQ39298765-6F000A2A-A771-42D4-BAF3-55AF7F8BA411Q39412662-704403CD-8BCF-45ED-9BEB-30F545BD83B0Q39477514-8BA130DE-B70F-4C77-8E49-97EF6A4B7447Q39528204-5FC46B0B-1473-48EF-8C44-4BDB86DE872EQ39676024-A7A7BF37-8851-4303-9597-43BA4E0D5F17Q40373004-AD52C8F7-F70B-4F2F-AC7C-FE20727252CFQ40484728-D29B87AB-A726-4996-911B-201603E49804Q41701927-775052F2-D011-4D7F-80FD-A1B5DCBE2190Q42738854-78605CB1-467B-46D5-B871-6F45D71167E8Q42801075-96259BE5-9B1E-4C78-9488-62344F830869Q42814973-679B40A0-9007-4984-9875-6CEC09DBDA0FQ42837140-48C3E645-26DE-4E91-842D-518063D3C8CFQ43425542-19371468-7741-41FD-B063-498A55810A27Q49887893-06521224-0F22-4A5A-937D-DDC3E621EC63Q50985105-6FE851D9-2AD6-4F75-9721-9746B6BAA93E
P2860
Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Oncogenic and invasive potenti ...... RON receptor tyrosine kinase.
@ast
Oncogenic and invasive potenti ...... RON receptor tyrosine kinase.
@en
type
label
Oncogenic and invasive potenti ...... RON receptor tyrosine kinase.
@ast
Oncogenic and invasive potenti ...... RON receptor tyrosine kinase.
@en
prefLabel
Oncogenic and invasive potenti ...... RON receptor tyrosine kinase.
@ast
Oncogenic and invasive potenti ...... RON receptor tyrosine kinase.
@en
P2093
P2860
P356
P1433
P1476
Oncogenic and invasive potenti ...... RON receptor tyrosine kinase.
@en
P2093
Ming-Hai Wang
Yi-Qing Chen
P2860
P304
P356
10.1093/CARCIN/BGG089
P407
P577
2003-05-22T00:00:00Z